US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Celldex Therapeutics

31.26

-0.4600-1.45%

Pre-market: 29.06-2.2000-7.04%04:01 EDT

Volume:432.96K

Turnover:13.59M

Market Cap:2.08B

PE:-8.02

High:32.61

Open:31.94

Low:31.14

Close:31.72

52wk High:34.52

52wk Low:14.40

Shares:66.45M

Float Shares:53.21M

Volume Ratio:0.50

T/O Rate:0.81%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.9000

EPS(LYR):-3.9000

ROE:-40.62%

ROA:-26.12%

PB:3.94

PE(LYR):-8.02

Loading ...

Overview Company News Filings

Clinical-stage biotech Celldex's Q3 net loss widens to $67 mln

Celldex Therapeutics reports third quarter net loss of $67.0 million on revenue of $0.0 million

Tech Rallies, Palantir Jumps 6% As Shutdown End Looms: What's Moving Markets Monday?

Benzinga_recent_news

Celldex Therapeutics Appoints Teri Lawver as Chief Commercial Officer

Celldex Announces Appointment of Teri Lawver as Chief Commercial Officer

THOMSON REUTERS

Celldex Therapeutics to Participate in Guggenheim Healthcare Innovation Conference

Celldex announces additional data on barzolvolimab

Celldex presents results from Barzolvolimab Phase 2 Study in ColdU, SD

Celldex Therapeutics Inc - Barzolvolimab Well Tolerated With Favorable Safety Profile Over 20 Weeks

THOMSON REUTERS

Celldex Therapeutics Inc: Presents Results From Barzolvolimab Phase 2 Study in Cold Urticaria (Coldu) and Symptomatic Dermographism (Sd)

THOMSON REUTERS

Celldex Therapeutics : All Primary and Secondary Endpoints Met With High Statistical Significance at 12 Weeks in Phase 2 Study

THOMSON REUTERS

Celldex Reports Barzolvolimab Shows Sustained Efficacy and Safety in Phase 2 Urticaria Study

Cantor Fitzgerald Sticks to Its Buy Rating for Celldex (CLDX)

Celldex Reports Positive Phase 1 Results for CDX-622 in Mast Cell Inhibition

Celldex Announces Initial Positive Results From Phase 1 Trial of Cdx-622 Demonstrating Favorable Safety and Pk Profile and Sustained Mast Cell Inhibition

THOMSON REUTERS

Celldex Therapeutics Inc - Cdx-622 Has Long Half-Life and No Immunogenicity

THOMSON REUTERS

Celldex Therapeutics Inc - Plans Phase 1B Study in Asthma Patients Next Year

THOMSON REUTERS

Celldex Therapeutics Inc - Cdx-622 Well Tolerated With Good Pharmacokinetic Profile

THOMSON REUTERS

Mizuho Initiates Celldex Therapeutics at Outperform With $48 Price Target

MT Newswires Live

Celldex Therapeutics Initiated at Underweight by Barclays

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CLDX/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CLDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLDX\",,,,,undefined,":{"symbol":"CLDX","market":"US","secType":"STK","nameCN":"Celldex Therapeutics","latestPrice":31.26,"timestamp":1775073600000,"preClose":31.72,"halted":0,"volume":432960,"hourTrading":{"tag":"盘前","latestPrice":29.06,"preClose":31.26,"latestTime":"04:01 EDT","volume":7,"amount":203.42,"timestamp":1775116895178,"change":-2.2,"changeRate":-0.070377,"amplitude":0},"delay":0,"changeRate":-0.014501891551071793,"floatShares":53206696,"shares":66449471,"eps":-3.9,"marketStatus":"Pre-Mkt","change":-0.46,"latestTime":"04-02 05:04:03 EDT","open":31.94,"high":32.61,"low":31.14,"amount":13586247.13248,"amplitude":0.046343,"askPrice":30.96,"askSize":110,"bidPrice":28.7,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-3.9,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1775136600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":515304000000,"exchange":"NASDAQ","adjPreClose":31.26,"preHourTrading":{"tag":"盘前","latestPrice":29.06,"preClose":31.26,"latestTime":"04:01 EDT","volume":7,"amount":203.42,"timestamp":1775116895178,"change":-2.2,"changeRate":-0.070377,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":30.18,"preClose":31.26,"latestTime":"19:59 EDT","volume":40118,"amount":1213942.2017,"timestamp":1775087973038,"change":-1.08,"changeRate":-0.034549,"amplitude":0.083493},"volumeRatio":0.49831810743361016,"impliedVol":0.4362,"impliedVolPercentile":0.264},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLDX\",,,,,undefined,":{"symbol":"CLDX","floatShares":53206696,"roa":"-26.12%","roe":"-40.62%","lyrEps":-3.9,"volumeRatio":0.49831810743361016,"shares":66449471,"dividePrice":0,"high":32.61,"amplitude":0.046343,"preClose":31.72,"low":31.14,"week52Low":14.4,"pbRate":"3.94","psRate":"1344.47","week52High":34.52,"institutionHeld":0.9897,"latestPrice":31.26,"committee":0.290323,"eps":-3.9,"divideRate":0,"volume":432960,"delay":0,"ttmEps":-3.9,"open":31.94,"prevYearClose":27.16,"prevWeekClose":30.3,"prevMonthClose":31.72,"prevQuarterClose":31.72,"fiveDayClose":31.68,"twentyDayClose":29.54,"sixtyDayClose":25.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CLDX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-25","symbol":"CLDX","fiscalQuarterEnding":"2025/12","expectedEps":1,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1771995600000,"reportTimeType":"post","actualEps":-1.22},{"market":"US","date":"2025-11-10","symbol":"CLDX","fiscalQuarterEnding":"2025/09","expectedEps":-0.88,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"post","actualEps":-1.01},{"market":"US","date":"2025-08-07","symbol":"CLDX","fiscalQuarterEnding":"2025/06","expectedEps":-0.86,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.85},{"market":"US","date":"2025-05-08","symbol":"CLDX","fiscalQuarterEnding":"2025/03","expectedEps":-0.75,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.81},{"market":"US","date":"2025-02-27","symbol":"CLDX","fiscalQuarterEnding":"2024/12","expectedEps":-0.75,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"post","actualEps":-0.71}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CLDX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CLDX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3125,"buy":0.5625,"hold":0.0625,"sell":0.0625,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5625,"analysts":16,"updateTime":1774324800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CLDX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CLDX","date":"2026-04-01","current":-8.015385,"percent":0.855144,"low":-39.608288,"twenty":-19.643732,"median":-15.002692,"eighty":-8.712971,"high":-6.362397,"avg":-15.769267,"sd":7.027316,"marketCap":2111484495},"quantilePoints":[{"date":"2021-04-09","current":-13.723974,"twenty":-3.780939,"median":-2.551412,"eighty":-0.573427,"marketCap":820419152},{"date":"2021-04-16","current":-15.605967,"twenty":-3.780939,"median":-2.551412,"eighty":-0.573427,"marketCap":932924724},{"date":"2021-04-23","current":-18.481971,"twenty":-3.810305,"median":-2.551412,"eighty":-0.573427,"marketCap":1104852253},{"date":"2021-04-30","current":-20.098895,"twenty":-3.822364,"median":-2.551412,"eighty":-0.573427,"marketCap":1201511970},{"date":"2021-05-07","current":-16.985787,"twenty":-3.860353,"median":-2.551412,"eighty":-0.573427,"marketCap":1081875763},{"date":"2021-05-14","current":-16.848956,"twenty":-3.887045,"median":-2.551412,"eighty":-0.573427,"marketCap":1073160543},{"date":"2021-05-21","current":-17.1164,"twenty":-3.908962,"median":-2.551412,"eighty":-0.573427,"marketCap":1090194837},{"date":"2021-05-28","current":-17.383843,"twenty":-3.937093,"median":-2.551412,"eighty":-0.573427,"marketCap":1107229132},{"date":"2021-06-04","current":-17.358965,"twenty":-3.953775,"median":-2.551412,"eighty":-0.573427,"marketCap":1105644546},{"date":"2021-06-11","current":-19.305706,"twenty":-4.276296,"median":-2.551412,"eighty":-0.573427,"marketCap":1229638363},{"date":"2021-06-18","current":-17.27811,"twenty":-8.035734,"median":-2.551412,"eighty":-0.573427,"marketCap":1100494643},{"date":"2021-06-25","current":-20.219991,"twenty":-8.413209,"median":-2.551412,"eighty":-0.573427,"marketCap":1287871881},{"date":"2021-07-02","current":-21.05342,"twenty":-8.678841,"median":-2.551412,"eighty":-0.573427,"marketCap":1340955496},{"date":"2021-07-09","current":-20.157795,"twenty":-8.86096,"median":-2.551412,"eighty":-0.573427,"marketCap":1283910417},{"date":"2021-07-16","current":-29.074524,"twenty":-9.174495,"median":-2.551412,"eighty":-0.573427,"marketCap":1851843652},{"date":"2021-07-23","current":-30.47674,"twenty":-9.389024,"median":-2.551412,"eighty":-0.573427,"marketCap":1941155009},{"date":"2021-07-30","current":-31.299469,"twenty":-9.54166,"median":-2.551412,"eighty":-0.573427,"marketCap":1993557081},{"date":"2021-08-06","current":-33.505501,"twenty":-9.651269,"median":-2.551412,"eighty":-0.573427,"marketCap":2212535726},{"date":"2021-08-13","current":-30.77438,"twenty":-9.760007,"median":-2.551412,"eighty":-0.573427,"marketCap":2032186175},{"date":"2021-08-20","current":-33.470306,"twenty":-9.883907,"median":-2.551412,"eighty":-0.573427,"marketCap":2210211634},{"date":"2021-08-27","current":-35.891712,"twenty":-10.066146,"median":-2.551412,"eighty":-0.573427,"marketCap":2370109174},{"date":"2021-09-03","current":-38.172338,"twenty":-10.253543,"median":-2.551412,"eighty":-0.573427,"marketCap":2520710345},{"date":"2021-09-10","current":-38.376468,"twenty":-10.378598,"median":-2.551412,"eighty":-0.573427,"marketCap":2534190080},{"date":"2021-09-17","current":-38.284962,"twenty":-10.664442,"median":-2.551412,"eighty":-0.573427,"marketCap":2528147440},{"date":"2021-09-24","current":-38.862157,"twenty":-11.099409,"median":-2.551412,"eighty":-0.573427,"marketCap":2566262552},{"date":"2021-10-01","current":-39.333768,"twenty":-13.023237,"median":-2.551412,"eighty":-0.573427,"marketCap":2597405386},{"date":"2021-10-08","current":-38.123065,"twenty":-13.234704,"median":-2.551412,"eighty":-0.573427,"marketCap":2517456616},{"date":"2021-10-15","current":-32.505967,"twenty":-13.606086,"median":-2.551412,"eighty":-0.573427,"marketCap":2146531509},{"date":"2021-10-22","current":-33.357682,"twenty":-13.712134,"median":-2.551412,"eighty":-0.573427,"marketCap":2202774539},{"date":"2021-10-29","current":-29.943781,"twenty":-13.909522,"median":-2.551412,"eighty":-0.573427,"marketCap":1977337601},{"date":"2021-11-05","current":-32.287759,"twenty":-14.022116,"median":-2.570964,"eighty":-0.573427,"marketCap":2132122138},{"date":"2021-11-12","current":-27.102151,"twenty":-14.205691,"median":-2.570964,"eighty":-0.573427,"marketCap":1958482707},{"date":"2021-11-19","current":-27.754359,"twenty":-14.316493,"median":-2.570964,"eighty":-0.573427,"marketCap":2005613218},{"date":"2021-11-26","current":-25.578179,"twenty":-14.351425,"median":-2.570964,"eighty":-0.573427,"marketCap":1848355969},{"date":"2021-12-03","current":-23.04038,"twenty":-14.523358,"median":-2.570964,"eighty":-0.573427,"marketCap":1664966952},{"date":"2021-12-10","current":-23.628013,"twenty":-14.635688,"median":-2.570964,"eighty":-0.573427,"marketCap":1707431076},{"date":"2021-12-17","current":-25.009919,"twenty":-14.739039,"median":-2.570964,"eighty":-0.573427,"marketCap":1807291762},{"date":"2021-12-23","current":-27.121523,"twenty":-14.836068,"median":-2.570964,"eighty":-0.573427,"marketCap":1959882624},{"date":"2021-12-31","current":-24.951801,"twenty":-15.271306,"median":-2.570964,"eighty":-0.573427,"marketCap":1803092014},{"date":"2022-01-07","current":-23.60864,"twenty":-15.503192,"median":-2.578215,"eighty":-0.573444,"marketCap":1706031160},{"date":"2022-01-14","current":-20.6059,"twenty":-15.622732,"median":-2.585467,"eighty":-0.573461,"marketCap":1489044155},{"date":"2022-01-21","current":-17.997068,"twenty":-15.780401,"median":-2.585467,"eighty":-0.573461,"marketCap":1300522112},{"date":"2022-01-28","current":-18.739681,"twenty":-16.055498,"median":-2.589368,"eighty":-0.573478,"marketCap":1354185565},{"date":"2022-02-04","current":-19.824542,"twenty":-16.355157,"median":-2.589368,"eighty":-0.573478,"marketCap":1432580870},{"date":"2022-02-11","current":-20.438005,"twenty":-16.46705,"median":-2.589368,"eighty":-0.573478,"marketCap":1476911548},{"date":"2022-02-18","current":-19.198164,"twenty":-16.804174,"median":-2.589368,"eighty":-0.573478,"marketCap":1387316914},{"date":"2022-02-25","current":-19.469379,"twenty":-17.04674,"median":-2.589368,"eighty":-0.573478,"marketCap":1406915740},{"date":"2022-03-04","current":-20.082984,"twenty":-17.27811,"median":-2.589368,"eighty":-0.573478,"marketCap":1416071287},{"date":"2022-03-11","current":-20.652996,"twenty":-17.401574,"median":-2.589368,"eighty":-0.573478,"marketCap":1456263410},{"date":"2022-03-18","current":-23.562709,"twenty":-17.580204,"median":-2.589368,"eighty":-0.573478,"marketCap":1661430174},{"date":"2022-03-25","current":-22.754087,"twenty":-17.742739,"median":-2.589368,"eighty":-0.573478,"marketCap":1604413442},{"date":"2022-04-01","current":-22.595014,"twenty":-17.889576,"median":-2.589368,"eighty":-0.573478,"marketCap":1593197036},{"date":"2022-04-08","current":-24.742501,"twenty":-18.074838,"median":-2.589368,"eighty":-0.573478,"marketCap":1744618520},{"date":"2022-04-14","current":-23.754922,"twenty":-18.421657,"median":-2.589368,"eighty":-0.573478,"marketCap":1674983331},{"date":"2022-04-22","current":-22.025002,"twenty":-18.627055,"median":-2.589368,"eighty":-0.573478,"marketCap":1553004913},{"date":"2022-04-29","current":-20.257057,"twenty":-18.699907,"median":-2.589368,"eighty":-0.573478,"marketCap":1428345331},{"date":"2022-05-06","current":-17.500329,"twenty":-18.889904,"median":-2.589368,"eighty":-0.573478,"marketCap":1347927852},{"date":"2022-05-13","current":-18.20447,"twenty":-18.889904,"median":-2.589368,"eighty":-0.573478,"marketCap":1402162896},{"date":"2022-05-20","current":-17.700645,"twenty":-18.902976,"median":-2.589368,"eighty":-0.573478,"marketCap":1363356787},{"date":"2022-05-27","current":-16.705136,"twenty":-18.902976,"median":-2.589368,"eighty":-0.573478,"marketCap":1286679656},{"date":"2022-06-03","current":-14.932643,"twenty":-18.902976,"median":-2.589368,"eighty":-0.573478,"marketCap":1150156960},{"date":"2022-06-10","current":-13.15408,"twenty":-18.902976,"median":-2.618734,"eighty":-0.573478,"marketCap":1013166721},{"date":"2022-06-17","current":-14.119239,"twenty":-18.902976,"median":-2.652622,"eighty":-0.573478,"marketCap":1087506134},{"date":"2022-06-24","current":-17.815979,"twenty":-18.90341,"median":-2.686199,"eighty":-0.573461,"marketCap":1372240113},{"date":"2022-07-01","current":-13.779309,"twenty":-18.90341,"median":-2.717596,"eighty":-0.573461,"marketCap":1061323699},{"date":"2022-07-08","current":-16.225591,"twenty":-18.90341,"median":-2.763868,"eighty":-0.573461,"marketCap":1249743722},{"date":"2022-07-15","current":-17.809908,"twenty":-18.90341,"median":-2.854454,"eighty":-0.573461,"marketCap":1371772570},{"date":"2022-07-22","current":-17.803838,"twenty":-18.971733,"median":-2.893556,"eighty":-0.573461,"marketCap":1371305026},{"date":"2022-07-29","current":-18.647593,"twenty":-18.971972,"median":-2.932658,"eighty":-0.573461,"marketCap":1436293570},{"date":"2022-08-05","current":-22.271491,"twenty":-19.027068,"median":-2.995948,"eighty":-0.573461,"marketCap":1715417028},{"date":"2022-08-12","current":-17.52074,"twenty":-19.027068,"median":-3.010781,"eighty":-0.573461,"marketCap":1746011862},{"date":"2022-08-19","current":-15.488466,"twenty":-19.027068,"median":-3.038145,"eighty":-0.573461,"marketCap":1543487583},{"date":"2022-08-26","current":-14.779751,"twenty":-19.027068,"median":-3.059243,"eighty":-0.573461,"marketCap":1472861332},{"date":"2022-09-02","current":-14.099197,"twenty":-19.027068,"median":-3.069792,"eighty":-0.573461,"marketCap":1405041424},{"date":"2022-09-09","current":-14.821993,"twenty":-19.027068,"median":-3.080341,"eighty":-0.573461,"marketCap":1477070844},{"date":"2022-09-16","current":-13.728413,"twenty":-19.027068,"median":-3.089129,"eighty":-0.573461,"marketCap":1368091266},{"date":"2022-09-23","current":-13.132342,"twenty":-19.027068,"median":-3.09089,"eighty":-0.573461,"marketCap":1308690380},{"date":"2022-09-30","current":-13.193357,"twenty":-19.027068,"median":-3.111989,"eighty":-0.573461,"marketCap":1314770786},{"date":"2022-10-07","current":-13.174583,"twenty":-19.027068,"median":-3.133899,"eighty":-0.573461,"marketCap":1312899892},{"date":"2022-10-14","current":-14.756284,"twenty":-19.027068,"median":-3.145091,"eighty":-0.573461,"marketCap":1470522715},{"date":"2022-10-21","current":-14.906475,"twenty":-19.027068,"median":-3.189861,"eighty":-0.573461,"marketCap":1485489867},{"date":"2022-10-28","current":-16.647754,"twenty":-19.027068,"median":-3.229968,"eighty":-0.573461,"marketCap":1659015289},{"date":"2022-11-04","current":-15.718446,"twenty":-19.027068,"median":-3.301786,"eighty":-0.573461,"marketCap":1566406034},{"date":"2022-11-11","current":-16.753756,"twenty":-19.027068,"median":-3.436096,"eighty":-0.573461,"marketCap":1775663628},{"date":"2022-11-18","current":-15.411678,"twenty":-19.027068,"median":-3.56358,"eighty":-0.573461,"marketCap":1633422139},{"date":"2022-11-25","current":-14.949506,"twenty":-19.027068,"median":-3.684894,"eighty":-0.573461,"marketCap":1584438314},{"date":"2022-12-02","current":-16.593774,"twenty":-19.027068,"median":-3.775879,"eighty":-0.573461,"marketCap":1758707689},{"date":"2022-12-09","current":-16.509338,"twenty":-19.027068,"median":-4.276296,"eighty":-0.573461,"marketCap":1749758721},{"date":"2022-12-16","current":-19.340145,"twenty":-19.121067,"median":-8.046608,"eighty":-0.573461,"marketCap":2049784645},{"date":"2022-12-23","current":-19.602339,"twenty":-19.305706,"median":-8.419423,"eighty":-0.573461,"marketCap":2077573545},{"date":"2022-12-30","current":-19.806762,"twenty":-19.35576,"median":-8.6602,"eighty":-0.573461,"marketCap":2099239467},{"date":"2023-01-06","current":-19.482352,"twenty":-19.445083,"median":-8.854082,"eighty":-0.573461,"marketCap":2064856591},{"date":"2023-01-13","current":-20.451137,"twenty":-19.476863,"median":-9.149521,"eighty":-0.573461,"marketCap":2167534222},{"date":"2023-01-20","current":-20.713331,"twenty":-19.58843,"median":-9.312628,"eighty":-0.573461,"marketCap":2195323122},{"date":"2023-01-27","current":-20.553348,"twenty":-19.678544,"median":-9.475735,"eighty":-0.573461,"marketCap":2178367183},{"date":"2023-02-03","current":-20.482245,"twenty":-19.720289,"median":-9.576163,"eighty":-0.573461,"marketCap":2170831210},{"date":"2023-02-10","current":-19.362365,"twenty":-19.811202,"median":-9.705106,"eighty":-0.573461,"marketCap":2052139636},{"date":"2023-02-17","current":-19.117947,"twenty":-19.811202,"median":-9.834049,"eighty":-0.573461,"marketCap":2026234729},{"date":"2023-02-24","current":-17.829196,"twenty":-19.811202,"median":-9.980184,"eighty":-0.573461,"marketCap":1889645219},{"date":"2023-03-03","current":-19.660381,"twenty":-19.811202,"median":-10.083338,"eighty":-0.573461,"marketCap":2208352301},{"date":"2023-03-10","current":-17.56742,"twenty":-19.811202,"median":-10.315436,"eighty":-0.573461,"marketCap":1973260500},{"date":"2023-03-17","current":-17.584231,"twenty":-19.811202,"median":-10.415541,"eighty":-0.573461,"marketCap":1975148787},{"date":"2023-03-24","current":-15.365189,"twenty":-19.811202,"median":-10.882785,"eighty":-0.573461,"marketCap":1725894829},{"date":"2023-03-31","current":-15.12143,"twenty":-19.808982,"median":-12.812631,"eighty":-0.573478,"marketCap":1698514660},{"date":"2023-04-06","current":-13.944665,"twenty":-19.808982,"median":-13.012658,"eighty":-0.573478,"marketCap":1566334531},{"date":"2023-04-14","current":-13.25962,"twenty":-19.811202,"median":-13.069098,"eighty":-0.573461,"marketCap":1489386812},{"date":"2023-04-21","current":-15.083606,"twenty":-19.811202,"median":-13.15408,"eighty":-0.573461,"marketCap":1694266013},{"date":"2023-04-28","current":-13.34806,"twenty":-19.811202,"median":-13.22095,"eighty":-0.573461,"marketCap":1499320841},{"date":"2023-05-05","current":-12.542401,"twenty":-19.811202,"median":-13.234477,"eighty":-0.573461,"marketCap":1487980248},{"date":"2023-05-12","current":-13.171711,"twenty":-19.811202,"median":-13.255354,"eighty":-0.573461,"marketCap":1562639149},{"date":"2023-05-19","current":-12.462741,"twenty":-19.811202,"median":-13.257273,"eighty":-0.595764,"marketCap":1478529755},{"date":"2023-05-26","current":-12.096307,"twenty":-19.813422,"median":-13.266074,"eighty":-0.600613,"marketCap":1435057483},{"date":"2023-06-01","current":-12.665873,"twenty":-19.813422,"median":-13.266074,"eighty":-0.60342,"marketCap":1502628514},{"date":"2023-06-09","current":-14.167456,"twenty":-19.815642,"median":-13.37086,"eighty":-0.619698,"marketCap":1680770322},{"date":"2023-06-15","current":-14.976001,"twenty":-19.817862,"median":-13.423337,"eighty":-0.639042,"marketCap":1776692834},{"date":"2023-06-23","current":-14.561771,"twenty":-19.819398,"median":-13.546858,"eighty":-0.657004,"marketCap":1727550266},{"date":"2023-06-30","current":-13.773141,"twenty":-19.820167,"median":-13.616375,"eighty":-0.676211,"marketCap":1633990378},{"date":"2023-07-07","current":-14.127626,"twenty":-19.820167,"median":-13.637866,"eighty":-0.683184,"marketCap":1676045075},{"date":"2023-07-14","current":-14.920239,"twenty":-19.820935,"median":-13.664776,"eighty":-0.689532,"marketCap":1770077488},{"date":"2023-07-21","current":-14.752954,"twenty":-19.820935,"median":-13.764858,"eighty":-0.691375,"marketCap":1750231451},{"date":"2023-07-28","current":-13.653652,"twenty":-19.821703,"median":-13.796895,"eighty":-0.69431,"marketCap":1619814637},{"date":"2023-08-04","current":-13.458486,"twenty":-19.822839,"median":-13.836869,"eighty":-0.699228,"marketCap":1596660927},{"date":"2023-08-11","current":-12.762013,"twenty":-19.822839,"median":-13.836869,"eighty":-0.703833,"marketCap":1443817562},{"date":"2023-08-18","current":-12.465416,"twenty":-19.822839,"median":-13.836869,"eighty":-0.707122,"marketCap":1410262391},{"date":"2023-08-24","current":-12.168819,"twenty":-19.822839,"median":-13.836869,"eighty":-0.71041,"marketCap":1376707220},{"date":"2023-09-01","current":-11.654997,"twenty":-19.823406,"median":-13.836869,"eighty":-0.715672,"marketCap":1318576431},{"date":"2023-09-08","current":-11.826271,"twenty":-19.823406,"median":-13.836869,"eighty":-0.718519,"marketCap":1337953361},{"date":"2023-09-14","current":-11.454481,"twenty":-19.823406,"median":-13.836869,"eighty":-0.720277,"marketCap":1295891245},{"date":"2023-09-22","current":-10.961546,"twenty":-19.823974,"median":-13.836869,"eighty":-0.726855,"marketCap":1240123496},{"date":"2023-09-29","current":-11.692594,"twenty":-19.824542,"median":-13.838963,"eighty":-0.734476,"marketCap":1322829903},{"date":"2023-10-06","current":-11.512965,"twenty":-19.832485,"median":-13.841056,"eighty":-0.736673,"marketCap":1302507758},{"date":"2023-10-13","current":-11.065981,"twenty":-19.840428,"median":-13.842945,"eighty":-0.739217,"marketCap":1251938697},{"date":"2023-10-19","current":-10.025804,"twenty":-19.856315,"median":-13.852801,"eighty":-0.741191,"marketCap":1134259296},{"date":"2023-10-27","current":-9.733385,"twenty":-19.882937,"median":-13.87434,"eighty":-0.745695,"marketCap":1101176733},{"date":"2023-11-03","current":-9.106267,"twenty":-19.882937,"median":-13.87434,"eighty":-0.750239,"marketCap":1134731904},{"date":"2023-11-10","current":-11.314401,"twenty":-19.882937,"median":-13.87434,"eighty":-0.754599,"marketCap":1409887498},{"date":"2023-11-17","current":-12.196556,"twenty":-19.882937,"median":-13.87434,"eighty":-0.75867,"marketCap":1519812784},{"date":"2023-11-24","current":-12.582772,"twenty":-19.882937,"median":-13.87434,"eighty":-0.761997,"marketCap":1567939277},{"date":"2023-12-01","current":-13.258652,"twenty":-19.882937,"median":-13.87434,"eighty":-0.76466,"marketCap":1652160641},{"date":"2023-12-08","current":-13.969642,"twenty":-19.876711,"median":-13.916149,"eighty":-0.768014,"marketCap":1740757140},{"date":"2023-12-15","current":-15.865616,"twenty":-19.876711,"median":-13.928477,"eighty":-0.771368,"marketCap":1977014471},{"date":"2023-12-22","current":-16.594162,"twenty":-19.876711,"median":-13.994608,"eighty":-0.773993,"marketCap":2067798538},{"date":"2023-12-29","current":-17.555316,"twenty":-19.882937,"median":-14.030514,"eighty":-0.776189,"marketCap":2187567880},{"date":"2024-01-05","current":-17.16471,"twenty":-19.889164,"median":-14.05303,"eighty":-0.776231,"marketCap":2138894494},{"date":"2024-01-12","current":-18.007365,"twenty":-19.889164,"median":-14.119239,"eighty":-0.781429,"marketCap":2243897752},{"date":"2024-01-19","current":-17.406095,"twenty":-19.89539,"median":-14.166181,"eighty":-0.786056,"marketCap":2168973553},{"date":"2024-01-26","current":-16.387887,"twenty":-19.889164,"median":-14.211269,"eighty":-0.792162,"marketCap":2042094615},{"date":"2024-02-02","current":-15.580343,"twenty":-19.889164,"median":-14.262457,"eighty":-0.799212,"marketCap":1941466493},{"date":"2024-02-09","current":-16.466886,"twenty":-19.889164,"median":-14.303394,"eighty":-0.804215,"marketCap":2051938671},{"date":"2024-02-16","current":-16.15089,"twenty":-19.889164,"median":-14.327956,"eighty":-0.815105,"marketCap":2012562449},{"date":"2024-02-23","current":-16.431775,"twenty":-19.889164,"median":-14.352518,"eighty":-0.822892,"marketCap":2047563535},{"date":"2024-03-01","current":-21.891252,"twenty":-19.965856,"median":-14.42731,"eighty":-0.829862,"marketCap":3096057832},{"date":"2024-03-08","current":-21.390203,"twenty":-20.092531,"median":-14.514484,"eighty":-0.838563,"marketCap":3025195085},{"date":"2024-03-15","current":-19.367791,"twenty":-20.201544,"median":-14.562067,"eighty":-0.845431,"marketCap":2739167271},{"date":"2024-03-22","current":-18.679988,"twenty":-20.201544,"median":-14.59682,"eighty":-0.851469,"marketCap":2641892045},{"date":"2024-03-28","current":-19.035277,"twenty":-20.201544,"median":-14.619616,"eighty":-0.858847,"marketCap":2692140175},{"date":"2024-04-05","current":-18.024071,"twenty":-20.210767,"median":-14.688202,"eighty":-0.872321,"marketCap":2549126268},{"date":"2024-04-12","current":-18.616218,"twenty":-20.210767,"median":-14.720951,"eighty":-0.882713,"marketCap":2632873150},{"date":"2024-04-19","current":-17.550352,"twenty":-20.210767,"median":-14.752954,"eighty":-0.896089,"marketCap":2482128761},{"date":"2024-04-26","current":-16.898348,"twenty":-20.201544,"median":-14.771583,"eighty":-0.908873,"marketCap":2389916470},{"date":"2024-05-03","current":-19.042099,"twenty":-20.201544,"median":-14.828819,"eighty":-0.922671,"marketCap":2693104991},{"date":"2024-05-10","current":-18.680024,"twenty":-20.201544,"median":-14.923406,"eighty":-0.959738,"marketCap":2706287100},{"date":"2024-05-17","current":-18.170486,"twenty":-20.201544,"median":-14.964661,"eighty":-0.977114,"marketCap":2632467287},{"date":"2024-05-24","current":-16.523586,"twenty":-20.201544,"median":-15.014367,"eighty":-1.033661,"marketCap":2393871103},{"date":"2024-05-31","current":-15.295236,"twenty":-20.201544,"median":-15.048631,"eighty":-1.077404,"marketCap":2215912623},{"date":"2024-06-07","current":-15.973103,"twenty":-20.201544,"median":-15.114307,"eighty":-1.114246,"marketCap":2314119340},{"date":"2024-06-14","current":-16.57363,"twenty":-20.210767,"median":-15.192777,"eighty":-1.279622,"marketCap":2401121263},{"date":"2024-06-21","current":-16.236971,"twenty":-20.219991,"median":-15.230457,"eighty":-4.99723,"marketCap":2352347458},{"date":"2024-06-28","current":-17.14686,"twenty":-20.242231,"median":-15.282803,"eighty":-8.052822,"marketCap":2484168554},{"date":"2024-07-05","current":-16.337059,"twenty":-20.242231,"median":-15.305023,"eighty":-8.400782,"marketCap":2366847778},{"date":"2024-07-12","current":-17.47897,"twenty":-20.242231,"median":-15.365189,"eighty":-8.66952,"marketCap":2532283254},{"date":"2024-07-15","current":-18.106793,"twenty":-20.242231,"median":-15.390405,"eighty":-8.693279,"marketCap":2623239810},{"date":"2024-08-02","current":-17.083168,"twenty":-20.293336,"median":-15.514064,"eighty":-9.213406,"marketCap":2474941077},{"date":"2024-08-09","current":-14.43433,"twenty":-20.293336,"median":-15.546918,"eighty":-9.443494,"marketCap":2168267265},{"date":"2024-08-16","current":-14.60643,"twenty":-20.293336,"median":-15.546918,"eighty":-9.54166,"marketCap":2194119427},{"date":"2024-08-23","current":-15.568424,"twenty":-20.293336,"median":-15.570432,"eighty":-9.651269,"marketCap":2338626386},{"date":"2024-08-30","current":-17.620385,"twenty":-20.293336,"median":-15.611643,"eighty":-9.744741,"marketCap":2646863708},{"date":"2024-09-06","current":-19.182522,"twenty":-20.293336,"median":-15.673879,"eighty":-9.819067,"marketCap":2881521798},{"date":"2024-09-13","current":-18.423518,"twenty":-20.293336,"median":-15.752664,"eighty":-9.883907,"marketCap":2767507133},{"date":"2024-09-20","current":-18.163161,"twenty":-20.293336,"median":-15.791584,"eighty":-10.058078,"marketCap":2728397451},{"date":"2024-09-27","current":-14.500522,"twenty":-20.293336,"median":-15.862308,"eighty":-10.183765,"marketCap":2178210404},{"date":"2024-10-04","current":-13.609133,"twenty":-20.293336,"median":-15.862308,"eighty":-10.322313,"marketCap":2044309460},{"date":"2024-10-11","current":-13.097246,"twenty":-20.293336,"median":-15.862308,"eighty":-10.493627,"marketCap":1967415849},{"date":"2024-10-18","current":-12.682441,"twenty":-20.293336,"median":-15.862308,"eighty":-10.788047,"marketCap":1905105509},{"date":"2024-10-25","current":-12.413259,"twenty":-20.293336,"median":-15.862308,"eighty":-10.996486,"marketCap":1864670075},{"date":"2024-10-31","current":-11.618951,"twenty":-20.293336,"median":-15.862308,"eighty":-11.10692,"marketCap":1745352402},{"date":"2024-11-08","current":-11.397755,"twenty":-20.295601,"median":-15.865616,"eighty":-11.285214,"marketCap":1756131926},{"date":"2024-11-15","current":-11.083423,"twenty":-20.295601,"median":-15.865616,"eighty":-11.3715,"marketCap":1707700634},{"date":"2024-11-22","current":-11.290107,"twenty":-20.295601,"median":-15.865616,"eighty":-11.385699,"marketCap":1739545867},{"date":"2024-11-29","current":-11.815429,"twenty":-20.295601,"median":-15.865616,"eighty":-11.479545,"marketCap":1820485835},{"date":"2024-12-06","current":-11.221213,"twenty":-20.295601,"median":-15.865616,"eighty":-11.507952,"marketCap":1728930790},{"date":"2024-12-13","current":-11.389143,"twenty":-20.295601,"median":-15.865616,"eighty":-11.525211,"marketCap":1754805042},{"date":"2024-12-20","current":-10.928411,"twenty":-20.295601,"median":-15.865616,"eighty":-11.525211,"marketCap":1683816709},{"date":"2024-12-27","current":-11.04467,"twenty":-20.295601,"median":-15.865616,"eighty":-11.525211,"marketCap":1701729653},{"date":"2025-01-03","current":-11.104953,"twenty":-20.295601,"median":-15.865616,"eighty":-11.525211,"marketCap":1711017846},{"date":"2025-01-10","current":-11.423591,"twenty":-20.297867,"median":-15.866533,"eighty":-11.549323,"marketCap":1760112581},{"date":"2025-01-17","current":-9.800261,"twenty":-20.297867,"median":-15.866533,"eighty":-11.549323,"marketCap":1509994811},{"date":"2025-01-24","current":-10.510737,"twenty":-20.297867,"median":-15.866533,"eighty":-11.549323,"marketCap":1619462800},{"date":"2025-01-31","current":-10.87674,"twenty":-20.297867,"median":-15.866533,"eighty":-11.549323,"marketCap":1675855401},{"date":"2025-02-07","current":-10.028474,"twenty":-20.297867,"median":-15.866533,"eighty":-11.549323,"marketCap":1545157256},{"date":"2025-02-14","current":-9.929438,"twenty":-20.297867,"median":-15.866533,"eighty":-11.549323,"marketCap":1529898082},{"date":"2025-02-21","current":-9.72706,"twenty":-20.297867,"median":-15.866533,"eighty":-11.549323,"marketCap":1498716291},{"date":"2025-02-28","current":-8.535575,"twenty":-20.297867,"median":-15.866533,"eighty":-11.549323,"marketCap":1347451433},{"date":"2025-03-07","current":-8.969592,"twenty":-20.300132,"median":-15.867451,"eighty":-11.563291,"marketCap":1415966688},{"date":"2025-03-14","current":-8.469179,"twenty":-20.300132,"median":-15.867451,"eighty":-11.563291,"marketCap":1336969953},{"date":"2025-03-21","current":-8.359845,"twenty":-20.300132,"median":-15.867451,"eighty":-11.563291,"marketCap":1319710162},{"date":"2025-03-28","current":-8.401896,"twenty":-20.300132,"median":-15.867451,"eighty":-11.563291,"marketCap":1326348543},{"date":"2025-04-04","current":-7.211838,"twenty":-20.300132,"median":-15.867451,"eighty":-11.563291,"marketCap":1138482358},{"date":"2025-04-11","current":-6.703014,"twenty":-20.297867,"median":-15.866533,"eighty":-11.549323,"marketCap":1058157947},{"date":"2025-04-17","current":-7.485173,"twenty":-20.297867,"median":-15.866533,"eighty":-11.549323,"marketCap":1181631835},{"date":"2025-04-25","current":-8.23369,"twenty":-20.300132,"median":-15.867451,"eighty":-11.563291,"marketCap":1299795019},{"date":"2025-05-02","current":-8.708922,"twenty":-20.300132,"median":-15.867451,"eighty":-11.563291,"marketCap":1374816595},{"date":"2025-05-09","current":-7.246342,"twenty":-20.300132,"median":-15.867451,"eighty":-11.563291,"marketCap":1296015584},{"date":"2025-05-16","current":-7.461654,"twenty":-20.300132,"median":-15.867451,"eighty":-11.563291,"marketCap":1334524244},{"date":"2025-05-23","current":-7.561885,"twenty":-20.300132,"median":-15.867451,"eighty":-11.563291,"marketCap":1352450689},{"date":"2025-05-30","current":-7.365135,"twenty":-20.300132,"median":-15.867451,"eighty":-11.563291,"marketCap":1317261741},{"date":"2025-06-06","current":-7.250055,"twenty":-20.300132,"median":-15.867451,"eighty":-11.563291,"marketCap":1296679526},{"date":"2025-06-13","current":-7.55446,"twenty":-20.300132,"median":-15.867451,"eighty":-11.563291,"marketCap":1351122804},{"date":"2025-06-20","current":-7.728937,"twenty":-20.302397,"median":-15.867451,"eighty":-11.588158,"marketCap":1382328097},{"date":"2025-06-27","current":-7.858866,"twenty":-20.302397,"median":-15.867451,"eighty":-11.588158,"marketCap":1405566081},{"date":"2025-07-03","current":-8.166984,"twenty":-20.302397,"median":-15.867451,"eighty":-11.588158,"marketCap":1460673302},{"date":"2025-07-11","current":-8.419418,"twenty":-20.302397,"median":-15.867451,"eighty":-11.588158,"marketCap":1505821385},{"date":"2025-07-18","current":-8.527074,"twenty":-20.302397,"median":-15.867451,"eighty":-11.588158,"marketCap":1525075715},{"date":"2025-07-25","current":-8.619881,"twenty":-20.302397,"median":-15.867451,"eighty":-11.588158,"marketCap":1541674276},{"date":"2025-08-01","current":-8.15956,"twenty":-20.302397,"median":-15.867451,"eighty":-11.588158,"marketCap":1459345417},{"date":"2025-08-08","current":-7.873715,"twenty":-20.302397,"median":-15.867451,"eighty":-11.588158,"marketCap":1408221851},{"date":"2025-08-15","current":-8.297117,"twenty":-20.302397,"median":-15.867451,"eighty":-11.588158,"marketCap":1656179207},{"date":"2025-08-22","current":-7.325682,"twenty":-20.302397,"median":-15.867451,"eighty":-11.588158,"marketCap":1462272098},{"date":"2025-08-29","current":-7.445448,"twenty":-20.302397,"median":-15.867451,"eighty":-11.588158,"marketCap":1486178454},{"date":"2025-09-05","current":-7.578521,"twenty":-20.302397,"median":-15.867451,"eighty":-11.612792,"marketCap":1512741072},{"date":"2025-09-12","current":-8.383615,"twenty":-20.302397,"median":-15.867451,"eighty":-11.588158,"marketCap":1673444908},{"date":"2025-09-19","current":-8.623146,"twenty":-20.302397,"median":-15.867451,"eighty":-11.588158,"marketCap":1721257620},{"date":"2025-09-26","current":-8.400249,"twenty":-20.302397,"median":-15.867451,"eighty":-11.588158,"marketCap":1676765236},{"date":"2025-10-03","current":-8.599859,"twenty":-20.302397,"median":-15.867451,"eighty":-11.522627,"marketCap":1716609162},{"date":"2025-10-10","current":-9.162093,"twenty":-20.302397,"median":-15.867451,"eighty":-11.44512,"marketCap":1828836221},{"date":"2025-10-17","current":-8.832737,"twenty":-20.302397,"median":-15.867451,"eighty":-11.414979,"marketCap":1763093743},{"date":"2025-10-24","current":-8.736259,"twenty":-20.302397,"median":-15.867451,"eighty":-11.332118,"marketCap":1743835845},{"date":"2025-10-31","current":-8.649761,"twenty":-20.302397,"median":-15.867451,"eighty":-11.285801,"marketCap":1726570144},{"date":"2025-11-07","current":-7.738209,"twenty":-20.302397,"median":-15.867451,"eighty":-11.212601,"marketCap":1544616213},{"date":"2025-11-14","current":-7.019852,"twenty":-20.302397,"median":-15.815767,"eighty":-11.083423,"marketCap":1576181452},{"date":"2025-11-21","current":-7.41938,"twenty":-20.302397,"median":-15.776194,"eighty":-10.984387,"marketCap":1665888237},{"date":"2025-11-28","current":-7.996476,"twenty":-20.302397,"median":-15.737025,"eighty":-10.932716,"marketCap":1795464706},{"date":"2025-12-05","current":-8.760018,"twenty":-20.302397,"median":-15.64731,"eighty":-10.825069,"marketCap":1966904341},{"date":"2025-12-12","current":-8.268747,"twenty":-20.302397,"median":-15.64731,"eighty":-10.756174,"marketCap":1856598219},{"date":"2025-12-19","current":-7.484488,"twenty":-20.302397,"median":-15.625267,"eighty":-10.566714,"marketCap":1680507121},{"date":"2025-12-26","current":-7.940246,"twenty":-20.302397,"median":-15.625267,"eighty":-10.471984,"marketCap":1782839306},{"date":"2026-01-02","current":-8.037908,"twenty":-20.302397,"median":-15.625267,"eighty":-10.239464,"marketCap":1804767632},{"date":"2026-01-09","current":-8.094138,"twenty":-20.302397,"median":-15.609281,"eighty":-10.028474,"marketCap":1817393031},{"date":"2026-01-16","current":-7.602867,"twenty":-20.302397,"median":-15.609281,"eighty":-9.877767,"marketCap":1707086909},{"date":"2026-01-23","current":-7.946165,"twenty":-20.302397,"median":-15.609281,"eighty":-9.800261,"marketCap":1784168296},{"date":"2026-01-30","current":-7.30692,"twenty":-20.302397,"median":-15.568314,"eighty":-9.705531,"marketCap":1640637438},{"date":"2026-02-06","current":-6.682473,"twenty":-20.302397,"median":-15.483933,"eighty":-9.445143,"marketCap":1500429055},{"date":"2026-02-13","current":-6.97546,"twenty":-20.302397,"median":-15.377797,"eighty":-9.184515,"marketCap":1566214031},{"date":"2026-02-20","current":-6.966582,"twenty":-20.219991,"median":-15.30013,"eighty":-9.095556,"marketCap":1564220547},{"date":"2026-02-27","current":-7.868432,"twenty":-20.082984,"median":-15.246018,"eighty":-8.969592,"marketCap":2036011791},{"date":"2026-03-06","current":-7.552986,"twenty":-19.931193,"median":-15.206618,"eighty":-8.89262,"marketCap":1954387918},{"date":"2026-03-13","current":-7.686758,"twenty":-19.817862,"median":-15.114307,"eighty":-8.861178,"marketCap":1989002418},{"date":"2026-03-20","current":-7.725346,"twenty":-19.676019,"median":-15.044932,"eighty":-8.786161,"marketCap":1998987370},{"date":"2026-03-27","current":-8.167823,"twenty":-19.643732,"median":-15.002692,"eighty":-8.736259,"marketCap":2113481485},{"date":"2026-04-01","current":-8.160106,"twenty":-19.643732,"median":-15.002692,"eighty":-8.712971,"marketCap":2111484495}],"updateTime":1775120643254},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CLDX\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2582004148","title":"Clinical-stage biotech Celldex's Q3 net loss widens to $67 mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2582004148","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582004148?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:11","pubTimestamp":1762809105,"startTime":"0","endTime":"0","summary":"Clinical-stage biotech Celldex'sQ3 net loss widens to $67 mlnOverviewCelldex Q3 net loss widens to $67 mln, below analysts' expectationsCompany reports zero revenue in Q3, down from $3.2 mln in prior ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nL1N3WM11C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582432807","title":"Celldex Therapeutics reports third quarter net loss of $67.0 million on revenue of $0.0 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2582432807","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582432807?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:01","pubTimestamp":1762808492,"startTime":"0","endTime":"0","summary":"Celldex Therapeutics Inc. reported a net loss of $67.0 million, or  per share, for the third quarter of 2025, compared to a net loss of $42.1 million, or  per share, for the same period in 2024. For the nine months ended September 30, 2025, net loss was $177.4 million, or  per share, versus $110.8 million, or  per share, for the corresponding period in 2024. Total revenue was $0.0 million in the third quarter of 2025 and $1.4 million for the nine-month period, compared to $3.2 million and $5.8 million, respectively, in 2024, primarily due to a decrease in services performed under agreements with Rockefeller University. Cash, cash equivalents and marketable securities totaled $583.2 million as of September 30, 2025. The company highlighted positive Phase 2 results for barzolvolimab in chronic spontaneous urticaria, cold urticaria, and symptomatic dermographism, as well as positive Phase 1 data for CDX-622. Celldex expects its cash position to fund planned operations through 2027.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL6ZBZsV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582809801","title":"Tech Rallies, Palantir Jumps 6% As Shutdown End Looms: What's Moving Markets Monday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2582809801","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582809801?lang=en_us&edition=fundamental","pubTime":"2025-11-11 01:31","pubTimestamp":1762795860,"startTime":"0","endTime":"0","summary":"Wall Street rebounded on Monday, recovering part of last week's steep losses as investors grew more confident about risk assets amid encouraging signs from Washington that the record-long government shutdown may soon conclude.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/11/10/wall-street-midjourney.png?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/11/10/wall-street-midjourney.png?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/25/11/48759870/stocks-today-monday-wall-street-shutdown-market-palantir-tech-nasdaq-rebound-bitcoin-gold","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/25/11/48759870/stocks-today-monday-wall-street-shutdown-market-palantir-tech-nasdaq-rebound-bitcoin-gold","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["IE00BZ9MQY76.HKD","QID","IE00B19Z9Z06.USD","TSYW.SI","PLTR","IE00B19Z9P08.USD","NVIW.SI","BK4139","CLDX","LU1861558580.USD","BK4585","BK4009","IPG","LU0477156797.USD","LU1201861165.SGD","TQQQ","QLD","ETH.USD.HKCC","FRHC","BK4541","NQmain","LU2249611893.SGD","BK4023","BK4096","DDS","LU1720051017.SGD","LU1720051108.HKD","PSQ","BK4103","USJW.SI","BK4179","BTC.USD.HKCC","LU0648000940.SGD",".IXIC","BK4547","LU0130518102.USD","LU1548497426.USD","BK4127","BK4220","USAW.SI","LU2357305700.SGD","BK4543","LU0823414478.USD","SQQQ","IE00B894F039.SGD","TDW","MNQmain"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2582387971","title":"Celldex Therapeutics Appoints Teri Lawver as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2582387971","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582387971?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:06","pubTimestamp":1762779960,"startTime":"0","endTime":"0","summary":"Celldex Therapeutics Inc. has appointed Teri Lawver as Senior Vice President and Chief Commercial Officer, succeeding Richard Wright, who is retiring. Lawver brings extensive experience from her previous roles at Dexcom, Johnson & Johnson, and as Principal of Thera Lifescience Advisors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celldex Therapeutics Inc. published the original content used to generate this news brief on November 10, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL9GzccG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLDX","LU2750360641.GBP","BK4550","JNJ","BK4559","LU1196500208.SGD","IE00B42XCP33.USD","LU2471134523.USD","LU2505996509.AUD","IE00B1BXHZ80.USD","LU0070217475.USD","LU2468319806.SGD","LU2430703095.HKD","LU2471134796.USD","LU0098860793.USD","LU1914381329.SGD","LU1778281490.HKD","LU1894683348.USD","LU2430703178.SGD","LU2347655156.SGD","IE00BJJMRZ35.SGD","LU0345770993.USD","LU2471134879.HKD","LU0640476718.USD","IE00B3T34201.USD","LU1221951046.USD","LU1221951129.SGD","LU2750360997.AUD","LU1496350502.SGD","IE00B19Z3B42.SGD","LU2592432038.USD","LU2089984988.USD","DXCM","LU1323610961.USD","LU2129689431.USD","LU2125909247.SGD","IE0002141913.USD","LU2430703251.USD","LU2112291526.USD","LU0234572021.USD","LU2129689605.HKD","BK4551","BK4532","LU2505996681.GBP","LU2129689514.USD","LU0122379950.USD","LU0203345920.USD","LU1267930813.SGD","LU0912757837.SGD","LU1935042991.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582879170","title":"Celldex Announces Appointment of Teri Lawver as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2582879170","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582879170?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:01","pubTimestamp":1762779660,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nTUA9NN8G1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CLDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581888204","title":"Celldex Therapeutics to Participate in Guggenheim Healthcare Innovation Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2581888204","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581888204?lang=en_us&edition=fundamental","pubTime":"2025-11-07 21:01","pubTimestamp":1762520491,"startTime":"0","endTime":"0","summary":"Celldex Therapeutics Inc. will participate in a fireside chat at the Guggenheim 2nd Annual Healthcare Innovation Conference on November 11. The company will also attend the TD Cowen Immunology & Inflammation Summit on November 13 and the 8th Annual Evercore Healthcare Conference on December 2. Live webcasts of the presentations will be available on the Celldex website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celldex Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on November 07, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nNDL2GpTSl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","CLDX","EVR","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU0314104364.USD","LU2095319765.USD","LU2210150020.SGD","BK4588","BK4139","NDAQ","IE00B3QW5Z07.USD","BK4127","BK4585","BK4112","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581096500","title":"Celldex announces additional data on barzolvolimab","url":"https://stock-news.laohu8.com/highlight/detail?id=2581096500","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581096500?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:37","pubTimestamp":1762436265,"startTime":"0","endTime":"0","summary":"Celldex (CLDX) announced new data on exploratory endpoints further demonstrating barzolvolimab’s ability to improve urticaria control from the Comp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/celldex-announces-additional-data-on-barzolvolimab-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/celldex-announces-additional-data-on-barzolvolimab-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CLDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581660096","title":"Celldex presents results from Barzolvolimab Phase 2 Study in ColdU, SD","url":"https://stock-news.laohu8.com/highlight/detail?id=2581660096","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581660096?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:36","pubTimestamp":1762436188,"startTime":"0","endTime":"0","summary":"Celldex (CLDX) announced new data demonstrating sustained efficacy and a well tolerated safety profile over a 20 week treatment period for barzolvo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/celldex-presents-results-from-barzolvolimab-phase-2-study-in-coldu-sd-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/celldex-presents-results-from-barzolvolimab-phase-2-study-in-coldu-sd-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SD","BK4139","BK4213","CLDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581931110","title":"Celldex Therapeutics Inc - Barzolvolimab Well Tolerated With Favorable Safety Profile Over 20 Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2581931110","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581931110?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:04","pubTimestamp":1762434278,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI0ZN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CLDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581093931","title":"Celldex Therapeutics Inc: Presents Results From Barzolvolimab Phase 2 Study in Cold Urticaria (Coldu) and Symptomatic Dermographism (Sd)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581093931","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581093931?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:04","pubTimestamp":1762434278,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI0ZN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581009319","title":"Celldex Therapeutics : All Primary and Secondary Endpoints Met With High Statistical Significance at 12 Weeks in Phase 2 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2581009319","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581009319?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:04","pubTimestamp":1762434278,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI0ZN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581098022","title":"Celldex Reports Barzolvolimab Shows Sustained Efficacy and Safety in Phase 2 Urticaria Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2581098022","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581098022?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:00","pubTimestamp":1762434057,"startTime":"0","endTime":"0","summary":"Celldex Therapeutics Inc. announced new data from a Phase 2 study evaluating barzolvolimab in patients with cold urticaria  and symptomatic dermographism , two forms of chronic inducible urticaria. Results presented by the company showed sustained efficacy and a favorable safety profile for barzolvolimab over a 20-week, placebo-controlled treatment period. The study met all primary and secondary endpoints with high statistical significance at 12 weeks, which was maintained through week 20. Up to 66% of ColdU patients and 49% of SD patients achieved complete response at week 20, with partial or complete response observed in up to 78% and 58% of patients, respectively. Barzolvolimab was generally well tolerated, with most adverse events being mild and reversible. Celldex plans to initiate a Phase 3 study in ColdU and SD in December 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and time","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL846X85:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2210149790.SGD","BK4139","BK4588","IE00B3QW5Z07.USD","BK4585","LU2095319765.USD","BK4112","IE00B64PRP62.GBP","CLDX","NDAQ","IE00BGHQF748.EUR","LU2210150020.SGD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579231495","title":"Cantor Fitzgerald Sticks to Its Buy Rating for Celldex (CLDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2579231495","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579231495?lang=en_us&edition=fundamental","pubTime":"2025-10-31 22:57","pubTimestamp":1761922638,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on Celldex, with a price target of $67.00. The compan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-sticks-to-its-buy-rating-for-celldex-cldx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-sticks-to-its-buy-rating-for-celldex-cldx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579288171","title":"Celldex Reports Positive Phase 1 Results for CDX-622 in Mast Cell Inhibition","url":"https://stock-news.laohu8.com/highlight/detail?id=2579288171","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579288171?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:01","pubTimestamp":1761854485,"startTime":"0","endTime":"0","summary":"Celldex Therapeutics Inc. has announced initial positive results from an ongoing Phase 1 clinical trial of CDX-622, a novel bispecific antibody targeting inflammation and fibrosis by depleting mast cells through stem cell factor  starvation and neutralizing thymic stromal lymphopoietin . The Phase 1 study, conducted in healthy volunteers, demonstrated that CDX-622 was well tolerated, showed a favorable pharmacokinetic profile, and resulted in rapid and sustained reductions in serum tryptase, indicating mast cell inhibition and depletion. The data were presented at the Collegium Internationale Allergologicum  Biennial Symposium. Based on these results, the study has progressed to testing multiple ascending doses, with completion expected next year and plans to initiate a Phase 1b proof of mechanism study in patients with mild to moderate asthma.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL6nbzKW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2210150020.SGD","CLDX","LU0314104364.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4139","LU2095319765.USD","NDAQ","BK4588","BK4585","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579719511","title":"Celldex Announces Initial Positive Results From Phase 1 Trial of Cdx-622 Demonstrating Favorable Safety and Pk Profile and Sustained Mast Cell Inhibition","url":"https://stock-news.laohu8.com/highlight/detail?id=2579719511","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579719511?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:01","pubTimestamp":1761854460,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nTUA7FLTFP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579424171","title":"Celldex Therapeutics Inc - Cdx-622 Has Long Half-Life and No Immunogenicity","url":"https://stock-news.laohu8.com/highlight/detail?id=2579424171","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579424171?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:01","pubTimestamp":1761854460,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nTUA7FLTFP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CLDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579171425","title":"Celldex Therapeutics Inc - Plans Phase 1B Study in Asthma Patients Next Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2579171425","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579171425?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:01","pubTimestamp":1761854460,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nTUA7FLTFP:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CLDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579171421","title":"Celldex Therapeutics Inc - Cdx-622 Well Tolerated With Good Pharmacokinetic Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2579171421","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579171421?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:01","pubTimestamp":1761854460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nTUA7FLTFP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CLDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577559829","title":"Mizuho Initiates Celldex Therapeutics at Outperform With $48 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2577559829","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577559829?lang=en_us&edition=fundamental","pubTime":"2025-10-21 18:40","pubTimestamp":1761043208,"startTime":"0","endTime":"0","summary":"Celldex Therapeutics (CLDX) has an average rating of overweight and mean price target of $53.43, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CLDX","MFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575540612","title":"Celldex Therapeutics Initiated at Underweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2575540612","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575540612?lang=en_us&edition=fundamental","pubTime":"2025-10-13 20:25","pubTimestamp":1760358300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CLDX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 13, 2025 08:25 ET (12:25 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLDX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":83,"code":"91000000","status":"200"}]}}